VERNALIS (R&D) LIMITED
Get an alert when VERNALIS (R&D) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£3.8M
-21.8% vs 2024
Net assets
£5.9M
+166.7% vs 2024
Employees
73
0% vs 2024
Profit before tax
£3.9M
+364.2% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £10,056,000 | £12,811,000 | £16,007,000 | +24.9% | |
| Operating profit | -£2,604,000 | £1,380,000 | £3,845,000 | +178.6% | |
| Profit before tax | -£3,074,000 | £849,000 | £3,941,000 | +364.2% | |
| Net profit | -£2,065,000 | £201,000 | £3,696,000 | +1,738.8% | |
| Cash | — | £4,840,000 | £3,785,000 | -21.8% | |
| Total assets less current liabilities | — | £3,250,000 | £6,642,000 | +104.4% | |
| Net assets | — | £2,217,000 | £5,913,000 | +166.7% | |
| Equity | — | £2,217,000 | £5,913,000 | +166.7% | |
| Average employees | 80 | 73 | 73 | 0% | |
| Wages | £5,351,000 | £5,077,000 | £5,504,000 | +8.4% | |
| Directors' remuneration | £178,000 | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -25.9% | 10.8% | 24.0% | |
| Net margin | -20.5% | 1.6% | 23.1% | |
| Return on capital employed | — | 42.5% | 57.9% | |
| Gearing (liabilities / total assets) | — | 84.3% | 60.1% | |
| Current ratio | — | 0.79x | 1.16x | |
| Interest cover | -5.54x | 2.60x | 22.75x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 7 times since incorporation
- VERNALIS (R&D) LIMITED 2003-12-18 → present
- VERNALIS (OXFORD) LIMITED 2003-10-01 → 2003-12-18
- BRITISH BIOTECH PHARMACEUTICALS LIMITED 1994-07-29 → 2003-10-01
- BRITISH BIO-TECHNOLOGY LIMITED 1994-06-03 → 1994-07-29
- BRITISH BIO-TECHNOLOGY LIMITED 1988-07-15 → 1994-06-03
- BRITISH BIOTECHNOLOGY LIMITED 1986-08-18 → 1988-07-15
- BIOTECHNOLOGY (UK) LIMITED 1986-04-04 → 1986-08-18
- GROWTRIM LIMITED 1986-02-04 → 1986-04-04
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company adopts the going concern basis in preparing the financial statements. This basis is dependent on the continuing financial support from its ultimate parent company, HitGen Inc. HitGen Inc. had adequate cash reserves at 31 December 2025 (£50.8 million) to support the Company. After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operation for the foreseeable future.”
Significant events
- “On 2 July 2025, the Company executed an extension agreement for its lease of its premises on Granta Park, lengthening the lease by 18 months and remeasuring the lease liability.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 40 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WALLCRAFT, Susan Jean | Secretary | 2020-12-02 | — | — |
| LI, Jin, Dr | Director | 2020-12-02 | Feb 1963 | British |
| LI, Michael | Director | 2020-12-02 | May 1996 | British |
Show 40 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BERKMAN, Charles Stuart | Secretary | 2019-04-01 | 2020-12-02 |
| BOND, Jonathan Charles Howard | Secretary | 2001-01-26 | 2004-06-30 |
| HOOD, Alison Mary | Secretary | 2009-09-30 | 2010-11-30 |
| ILETT, John Edward | Secretary | 1999-08-02 | 2000-08-18 |
| KISSANE, Kevin Patrick | Secretary | 2010-11-30 | 2017-11-01 |
| MACKNEY, David | Secretary | 2017-11-01 | 2018-01-25 |
| SLATER, John Andrew Duncan | Secretary | 2004-10-29 | 2009-09-30 |
| WALLCRAFT, Susan Jean | Secretary | 2018-01-25 | 2019-03-31 |
| WEIR, Anthony John | Secretary | — | 2001-01-26 |
| WORRALL, Peter Brian | Secretary | 2004-06-30 | 2004-10-29 |
| BERKMAN, Charles Stuart | Director | 2018-10-12 | 2020-12-02 |
| DOVEY, Brian Hugh | Director | — | 1993-03-23 |
| DRUMMOND, Alan Hastings | Director | 1994-05-26 | 2000-03-17 |
| EDWARDS, Timothy Peter Warren | Director | 2001-08-03 | 2003-09-10 |
| FALLEN, Malcolm James | Director | 1997-10-01 | 1999-03-31 |
| FELLNER, Peter John, Dr | Director | 2008-11-14 | 2014-12-18 |
| FOEHR, Matthew William | Director | 2018-10-12 | 2020-12-02 |
| GARLAND, Ian | Director | 2009-06-15 | 2018-10-12 |
| GOLDSTEIN, Elliot Paul, Dr | Director | 1998-09-24 | 2002-11-04 |
| GORDON, John Laurie, Dr | Director | — | 1994-06-24 |
| GRAY, Stephen Marius | Director | — | 1993-03-23 |
| HUTCHISON, John Blundell, Dr | Director | 2004-10-01 | 2007-08-31 |
| IRWIN, Thomas Ronald | Director | 1993-03-23 | 1996-09-30 |
| JACK, David, Sir | Director | — | 1993-03-23 |
| JENSEN, Peder Klosterskov, Doctor | Director | 1998-01-26 | 1999-07-31 |
| KIRBY, Pamela Josephine, Dr | Director | 1996-09-02 | 1998-09-30 |
| KORENBERG, Matthew Edward | Director | 2018-10-12 | 2020-12-02 |
| LEATHERS, David Frederick James | Director | — | 1993-03-23 |
| LEWIS, Peter John, Dr | Director | 1992-07-09 | 1997-06-30 |
| MACKNEY, David | Director | 2009-06-15 | 2018-10-12 |
| MCCULLAGH, Keith Graham, Dr | Director | — | 1998-09-23 |
| MOLONEY, Brian | Director | 2022-11-07 | 2024-10-04 |
| NOBLE, James Julian | Director | — | 1997-02-12 |
| REECE, Charles Hugh, Sir | Director | — | 1993-03-23 |
| RICHARDS, Brian Mansel, Sir | Director | — | 1993-03-23 |
| SLATER, John Andrew Duncan | Director | 2008-04-20 | 2009-09-30 |
| STURGE, Simon | Director | 2003-04-23 | 2008-02-29 |
| WEIR, Anthony John | Director | 1999-03-31 | 2008-11-14 |
| WEIR, Anthony John | Director | 1997-02-12 | 1997-10-01 |
| WOOD, Lars Michael | Director | 2020-12-02 | 2023-08-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Hitgen Uk Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-02 | Active |
| Vernalis Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2020-12-02 |
Filing timeline
Last 20 of 251 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-24 | AA | accounts | Accounts with accounts type full | |
| 2025-10-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-13 | AA | accounts | Accounts with accounts type full | |
| 2024-10-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-18 | AA | accounts | Accounts with accounts type full | |
| 2023-10-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-30 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-24 | AA | accounts | Accounts with accounts type full | |
| 2022-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-07-01 | AA | accounts | Accounts with accounts type full | |
| 2021-10-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-07-22 | AA | accounts | Accounts with accounts type full | |
| 2020-12-04 | AP03 | officers | Appoint person secretary company with name date | |
| 2020-12-02 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2020-12-02 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2020-12-02 | AP01 | officers | Appoint person director company with name date | |
| 2020-12-02 | AP01 | officers | Appoint person director company with name date | |
| 2020-12-02 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.